Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

IMNM
Immunome, Inc.
stock NASDAQ

Market Open
Aug 11, 2026 3:22:40 PM EDT
26.34USD+2.610%(+0.67)590,756
26.32Bid   26.37Ask   0.05Spread
Pre-market
Aug 6, 2026 9:28:30 AM EDT
25.45USD+1.678%(+0.42)0
After-hours
Aug 10, 2026 4:40:30 PM EDT
25.69USD+0.078%(+0.02)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 11, 2022
08:36AM EST  The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In   Benzinga
Jan 10, 2022
04:28PM EST  Immunome Reports Received FDA Clinical Hold Letter Related To Its Recently-Submitted Investigational New Drug Application Requesting Further Info; Co. Has Initiated Requisite Work   Benzinga
04:15PM EST  Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19   Business Wire
Dec 7, 2021
07:00AM EST  Immunome to Participate in Fireside Chat Hosted by Cantor Fitzgerald   Business Wire
Dec 1, 2021
08:41AM EST  The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case   Benzinga
08:36AM EST  The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment, Regulatory Setbacks For CTI Biopharma, Favorable Ruling For BioXcel, Viatris In Tecfidera Patent Case   Benzinga
07:40AM EST  Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529).   RTTNews
07:14AM EST  Immunome Says Expects IMM-BCP-01 Antibody Cocktail To Neutralize SARS-CoV-2 Omicron Variant   Benzinga
07:13AM EST  Immunome Expects IMM-BCP-01 Antibody Cocktail To Neutralize Omicron Variant; Stock Surges   RTTNews
07:00AM EST  Immunome Expects IMM-BCP-01 Antibody Cocktail To Neutralize the SARS-CoV-2 Omicron Variant   Business Wire
Nov 30, 2021
04:11PM EST  Why Are Immunome Shares Trading Higher Today?   Benzinga
Nov 29, 2021
07:12AM EST  Immunome Says Submits IND Application For IMM-BCP-01 For Treatment Of COVID-19   RTTNews
07:03AM EST  Immunome Announces Submission Of An Investigational New Drug Application For IMM-BCP-01 For The Treatment Of COVID-19   Benzinga
07:00AM EST  Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19   Business Wire
Nov 15, 2021
05:00PM EST  Immunome Reports Third Quarter 2021 Financial Results   Business Wire
Nov 9, 2021
04:06PM EST  Immunome to Present at the Stifel Healthcare Conference   Business Wire
Oct 29, 2021
10:05AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021   Benzinga
08:33AM EDT  Cantor Fitzgerald Initiates Coverage On Immunome with Overweight Rating, Announces Price Target of $35   Benzinga
Oct 20, 2021
08:02AM EDT  Immunome Announces Submission For Publication Of Pre-Clinical Research Detailing Importance Of Antibody Cocktail For SARS-CoV-2 Treatment And Prophylaxis   Benzinga
Oct 7, 2021
09:00AM EDT  Immunome Presents Compelling Preclinical Data on Anti-IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics   Business Wire
Sep 30, 2021
04:36PM EDT  Immunome To Present Preclinical Data On Anti IL-38 Antibody Program At The American Association For Cancer Research NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics   Benzinga
Sep 22, 2021
04:22PM EDT  Immunome To Present At Cantor Healthcare Conference Wednesday, Sept. 29 At 8:40 a.m. EDT   Benzinga
04:07PM EDT  Immunome to Present at the Cantor Global Healthcare Conference   Business Wire
Sep 15, 2021
04:05PM EDT  Immunome to Present At Oppenheimer Fall Healthcare Life Sciences And MedTech Summit   Benzinga
Sep 7, 2021
07:27AM EDT  Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda And Delta Plus Variants In Pre-clinical Testing   RTTNews
07:15AM EDT  Immunome Says Its IMM-BCP-01 'Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing'   Benzinga
07:00AM EDT  Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing   Business Wire
Aug 23, 2021
10:56AM EDT  Longboat Family Office Reports In 13G Filing A 5.59% Stake In Immunome   Benzinga
Aug 19, 2021
04:09PM EDT  Immunome Q2 EPS $(0.46) Misses $(0.39) Estimate   Benzinga
04:05PM EDT  Immunome Reports Second Quarter 2021 Financial Results   Business Wire
Jul 20, 2021
02:56PM EDT  Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher   Benzinga
12:10PM EDT  Mid-Day Market Update: HCA Healthcare Surges On Upbeat Results; Ardelyx Shares Slide   Benzinga
10:26AM EDT  Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results   Benzinga
08:21AM EDT  Immunome Stock Jumps As COVID-19 Antibody Shows Preclinical Neutralizing Activity Against Delta Variant   Benzinga
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
07:28AM EDT  Immunome Inc. (IMNM) said that its three-antibody cocktail (IMM-BCP-01) has neutralized the SARS-CoV-2 Delta variant in pre-clinical pseudovirus testing.   RTTNews
07:14AM EDT  Immunome Antibody Cocktail Neutralizes SARS-CoV-2 Delta Variant In Pre-clinical Testing; Stock Surges   RTTNews
07:05AM EDT  Immunome Antibody Cocktail Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing   Benzinga
07:03AM EDT  Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing   Business Wire
Jul 6, 2021
07:00AM EDT  Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference   Business Wire
Jun 30, 2021
07:00AM EDT  Immunome Appoints Andrew Badley, M.D., to COVID-19 Advisory Board   Business Wire
Jun 17, 2021
07:21AM EDT  Immunome Appoints Franklyn Prendergast To Board   RTTNews
07:00AM EDT  Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors   Business Wire
May 27, 2021
04:05PM EDT  Immunome to Present at the Jefferies Virtual Healthcare Conference   Business Wire
May 20, 2021
10:04AM EDT  Immunome Secures Additional $4.3M Funding From DoD To Develop COVID-19 Antibody Cocktail   Benzinga
07:55AM EDT  Immunome Announces $4.3 Mln Increase Awarded By DOD For Continued Development Of An Antibody Cocktail   RTTNews
07:06AM EDT  Immunome Announces Additional $4.3M Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern   Benzinga
07:00AM EDT  Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern   Business Wire
May 12, 2021
06:22AM EDT  Immunome Q1 Loss Per Share $0.37 Vs Loss Per Share $2.44 Last Year   RTTNews
06:08AM EDT  Immunome Q1 EPS $(0.37) Up From $(2.44) YoY   Benzinga
06:00AM EDT  Immunome Reports First Quarter 2021 Financial Results   Business Wire
Apr 26, 2021
11:05AM EDT  Immunome shares were trading higher after the company reported that its SARS-CoV-2 antibody cocktail neutralizes the UK, South Africa, Brazil, and California variants in its preclinical testing. Its currently progressing towards IND Filing.   Benzinga
08:37AM EDT  Immunome Raises $27M Via Private Equity Placement At 9%   Benzinga
08:09AM EDT  Immunome's Stock Jumps On Its Antibody Cocktail Neutralizing Multiple COVID-19 Variants In Animal Studies   Benzinga
06:03AM EDT  Immunome Reports Co.'s SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing   Benzinga
06:00AM EDT  Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing   Business Wire
05:50AM EDT  Immunome Announces $27 Million Private Placement   Business Wire
Apr 20, 2021
08:14AM EDT  Immunome Appoints Corleen Roche As Chief Financial Officer   Benzinga
08:06AM EDT  Immunome Appoints Corleen Roche As CFO   RTTNews
08:00AM EDT  Immunome Appoints Corleen Roche as Chief Financial Officer   Business Wire
Mar 30, 2021
08:13AM EDT  Immunome Appoints Dennis Giesing To The Role Of Chief Development Officer   RTTNews
08:00AM EDT  Immunome Appoints Dr. Dennis Giesing as Chief Development Officer   Business Wire
Mar 25, 2021
05:16PM EDT  Immunome Q4 EPS $(0.40) vs $(2.66) In Same Qtr. Last Year   Benzinga
05:14PM EDT  Immunome Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update   Business Wire
Mar 23, 2021
07:24AM EDT  Immunome Announces Advancement Of Antibody Against IL-38 To IND-Enabling Studies; Sees IND Filing By 2H 2021   Benzinga
07:12AM EDT  Immunome Advances Proprietary Antibody Against IL-38 Into IND-enabling Studies And Expects Filing An IND In H2 2021   RTTNews
07:00AM EDT  Immunome Advances Its Proprietary Antibody Against IL-38, a Novel Innate Immune Checkpoint, into IND-enabling Studies   Business Wire
Feb 19, 2021
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
Feb 18, 2021
03:36PM EST  Mid-Afternoon Market Update: Crude Oil Down 1.8%; HighCape Capital Acquisition Shares Surge   Benzinga
12:19PM EST  Mid-Day Market Update: Silver Down 1%; Greenland Technologies Shares Spike Higher   Benzinga
10:17AM EST  Mid-Morning Market Update: Markets Open Lower; Walmart Reports Downbeat Earnings   Benzinga
09:52AM EST  Shares of Immunome, Inc. (IMNM) are up more than 125% Thursday morning after the company announced the discovery of antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant, in pseudovirus testing.   RTTNews
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
07:04AM EST  Immunome Discovers Antibodies Capable of Neutralizing Multiple SARS-CoV-2 Variants, Including the South African Variant, in Pseudovirus Testing   Benzinga
Feb 4, 2021
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
07:03AM EST  Abzena Selected by Immunome To Develop And Manufacture Antibody Cocktail For Immunome's COVID-19 Antibody Based Treatment   Benzinga
Feb 1, 2021
07:02AM EST  Immunome Says Research Reveals 'Broad Super Responder Memory B Cell Response' To COVID-19   Benzinga
07:00AM EST  Immunome's Research Reveals a Broad Super Responder Memory B Cell Response to the SARS-CoV-2 Virus   Business Wire
Jan 27, 2021
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 13, 2021
03:12PM EST  Immunome 13G Filing From Alpine Global Shows New 7.5% Stake In Co.   Benzinga
Dec 30, 2020
08:16AM EST  The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 10, 2020
08:00AM EST  Immunome Provides Organizational Update: Appoints Richard Baron to its Board of Directors and Sandra Stoneman as Chief Legal Officer and Corporate Secretary   Business Wire
Dec 4, 2020
06:33AM EST  Immunome 8-K Shows CFO, Richard Fitzgerald, Resigned; Names Diane Marcou Interim CFO   Benzinga
Nov 25, 2020
07:35AM EST  The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback   Benzinga
Nov 18, 2020
09:39AM EST  Immunome shares were trading lower after the company reported Q3 EPS down from last year.   Benzinga
Nov 17, 2020
05:55PM EST  Immunome Q3 EPS $(7.52) Down From $(2.50) YoY   Benzinga
05:53PM EST  Immunome Reports Third Quarter 2020 Financial Results and Significant Progress   Business Wire
Oct 30, 2020
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 27, 2020
10:35AM EDT  Benzinga's Top Upgrades, Downgrades For October 27, 2020   Benzinga
06:16AM EDT  A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Earnings   Benzinga
05:00AM EDT  Chardan Capital Initiates Coverage On Immunome with Buy Rating, Announces Price Target of $18   Benzinga
Oct 13, 2020
04:05PM EDT  Immunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering   Business Wire
Oct 11, 2020
11:35AM EDT  Last Week's Notable Insider Buys: Element Solutions, Selecta Biosciences And More   Benzinga
Oct 2, 2020
11:37AM EDT  Immunome Shares Open For Trade At $15.66; IPO Priced At 12/Share   Benzinga
09:56AM EDT  Immunome Shares Expected To Open For Quote At 11:25 a.m. EDT, Expected To Open For Trade After 11:35 a.m. EDT; IPO Priced At 12/Share   Benzinga
05:41AM EDT  Immunome Priced Upsized 3.2M Share IPO @$12/Share   Benzinga
Oct 1, 2020
09:15PM EDT  Immunome Announces Pricing Of Upsized IPO Of 3.25 Mln Shares At $12/shr   RTTNews
08:23PM EDT  Immunome Announces Pricing of Upsized Initial Public Offering   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC